Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/1999
10/19/1999US5968477 Radiolabeled annexin conjugates with hexose and a chelator
10/19/1999CA1340790C Method of diagnosis and severity-assessment of human pancreatic disease
10/14/1999WO1999051750A1 Medicaments for inducing cytotoxic t-cells
10/14/1999WO1999051725A2 Assay for the diagnosis of schizophrenia based on a new peptide
10/14/1999WO1999051628A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
10/14/1999WO1999051627A1 Method for searching physiologically active substances, process for producing theses substances and drugs found by the searching method
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051625A2 Peptides causing formation of compact structures
10/14/1999WO1999051254A1 Short peptides for treatment of neurological degenerative diseases
10/14/1999WO1999044628A8 Conjugates useful in the treatment of prostate cancer
10/14/1999WO1999037678A3 Antimicrobial peptides
10/14/1999CA2327811A1 Short peptides for treatment of neurological degenerative diseases
10/14/1999CA2326978A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2324284A1 Peptides causing formation of compact structures
10/13/1999EP0948640A2 Improved substrates for human cytomegalovirus protease
10/13/1999EP0948539A2 Peptides and compounds that bind to a receptor
10/13/1999EP0948527A1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
10/13/1999EP0948526A1 Contryphan peptides
10/13/1999EP0948525A1 Cyclic peptide derivatives
10/13/1999EP0948524A1 Peptides agonists of bradykinine b 2? receptor
10/13/1999EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
10/13/1999EP0948344A1 Synthetic antibiotics
10/13/1999EP0948343A1 Alkyl peptide amides and applications
10/13/1999EP0777678B1 Pna combinatorial libraries and improved methods of synthesis
10/13/1999EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999EP0603307B1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
10/13/1999CN1231672A Conformationally constrained backbone cyclized somatostatin analogs
10/12/1999US5965700 Preparation of active peptides
10/12/1999US5965699 Assay for the proteolytic activity of serotype a from clostridium botulinum
10/12/1999US5965695 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
10/12/1999US5965537 Anticancer agents; water solubility
10/12/1999US5965536 Small peptides including the amino acid sequence arg arg trp trp cys xaa, wherein xaa is any amino acid residue are potent inhibitors of cxc intercrine molecules such as interleukin-8; treating inflammatory diseases such as cystic fibrosis
10/12/1999US5965532 Low molecular weight, synthetic crosslinking boron compounds as an agonists or antagonists and induce association between naturally occurring receptors, t cell surface receptor
10/12/1999US5965527 Cyclosporin a sulfided at the 3 position by r-(ch)n-s-by reacting a lithium-activated derivative with the disulfide; synergistic mixture with a retrovirus viricide; side-effect reduction; aids and arc (aids related complex)
10/12/1999US5965526 For design of compounds having biological activity; for inhibiting binding activity of nk2 receptors
10/12/1999US5965525 For inhibiting fungal and parasitic activities
10/12/1999US5965524 Analogs of viscosin and uses thereof
10/12/1999US5965383 Fibrin binding domain polypeptides and uses and methods of producing same
10/12/1999US5965357 Peptides structures and their use in diagnosis of herpes simplex virus type 2
10/12/1999US5965136 Bone resorption assay
10/12/1999US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability
10/12/1999US5965107 Electrically neutral complex comprising radioactive technetium, peptide, radiolabel binding moiety; radiolabelled peptide for medical diagnostic imaging
10/12/1999CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses
10/07/1999WO1999051051A2 A method for controlling connections to a mobile station
10/07/1999WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999WO1999050462A1 Aptamer based bacterial inhibition systems (abbis)
10/07/1999WO1999050405A1 Secreted proteins and polynucleotides encoding them
10/07/1999WO1999050281A2 Collagen peptides and uses thereof
10/07/1999WO1999049891A1 Compositions and methods for providing a vpr-binding protein to a virion
10/07/1999WO1999049879A1 Sequence and method for genetic engineering of proteins with cell membrane translocating activity
10/07/1999WO1999038888A3 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
10/07/1999DE19914474A1 New peptide aldehyde and boronic acid derivatives are proteinase inhibitors useful for treatment of viral infections, especially hepatitis
10/07/1999DE19814925A1 Arzneimittel zur Induktion zytotoxischer T-Zellen Drugs for the induction of cytotoxic T cells
10/07/1999CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999CA2325017A1 Collagen peptides and uses thereof
10/07/1999CA2324492A1 Secreted proteins and polynucleotides encoding them
10/06/1999EP0947200A2 Compositions comprising Cetrorelix acetate for the treatment of female infertility and gonadal protection
10/06/1999EP0946596A1 Peptide derivatives
10/06/1999EP0946594A2 Enteric neural peptide
10/06/1999EP0946590A2 Dihydroxypropyl cysteine peptide and agent containing this peptide
10/06/1999EP0946589A1 Inhibitors of peptide binding to mhc class ii proteins
10/06/1999EP0842190B1 Process for producing dolastatin 15 and intermediates thereof
10/06/1999EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
10/05/1999US5962642 Treating protein/peptide having amino terminal acetylated amino acid with acid to acetylate hydroxyl group, treating with isothiocyanate compound in presence of acid to form thiocarbamyl protein/peptide, analysis by edman degradation
10/05/1999US5962639 Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
10/05/1999US5962638 Peptides and synthetic cell membranes
10/05/1999US5962635 Therapeutic compounds
10/05/1999US5962415 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
10/05/1999US5962408 Disulphide-cyclo- H-Cys-Glu-Gln-Tyr-Cys-OH!, and its use in blood-clotting disorders
10/05/1999US5962407 Loloatin derivatives and analogs
10/05/1999US5962243 Assaying for presence of farnesyl protein transferase activity in an enzyme composition by determining transfer of moiety to k-rasb protein or k-rasb peptide having farnesyl acceptor
10/05/1999US5962236 Immunoassay using antibodies against free lysyl pyridinoline cross-links in unhydrolyzed urine sample
10/05/1999US5962220 St receptor binding moieties bind to the st receptor which is found on human colon cells. the invention relates to antisense compositions specifically targeted to colon cells.
10/05/1999US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
10/05/1999US5961978 Therapeutically useful peptides and peptide fragments
10/05/1999US5961977 Orally administering an autoantigen
10/05/1999CA2156863C Neuropeptides and their use as insecticides
10/05/1999CA2111336C Broad spectrum antimicrobial compounds and methods of use
09/1999
09/30/1999WO1999049059A2 Methods of cancer diagnosis using a chimeric toxin
09/30/1999WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999WO1999048913A1 Peptide turn mimetics
09/30/1999WO1999048912A1 A novel antimicrobial peptide isolated from parasilurus asotus and its uses
09/30/1999WO1999048513A1 Methods and compositions for peptide synthesis
09/30/1999WO1999040107A3 Method of promoting keratinocyte proliferation
09/30/1999DE19813849A1 Simultaneous purification of oligopeptide hydrochlorides and conversion to acetate form
09/30/1999CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999CA2323786A1 Methods of cancer diagnosis using a chimeric toxin
09/30/1999CA2264951A1 Amino acid derivatives
09/29/1999EP0945504A2 Materials and method for control of pests
09/29/1999EP0945461A1 Lipopeptides inducing T-cyxtotoxic lymphocytes and their use as vaccines
09/29/1999EP0944650A1 Antithrombotic peptides derived from fibronectin type ii repeats
09/29/1999EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
09/29/1999EP0944393A1 Use of peptides for improving the incorporation of skin grafts
09/29/1999EP0833842B1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases
09/29/1999EP0797447A4 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
09/29/1999CN1230195A Treatment of immune disorders
09/29/1999CN1230120A Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof
09/28/1999US5958882 Compounds that inhibit T cell proliferation and methods using the same
09/28/1999US5958732 Anticoagulants in snake venom